R. Eliaz

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) inhibitors and the risk for neurocognitive adverse events: A systematic review, meta-analysis and meta-regression.

H. Danenberg, C. Renoux, I. Matok, 2021, International journal of cardiology.

VHRM_A_298436 153..159

O. Amir, D. Planer, R. Alcalai, 2021 .

Long-Term Prognosis in Young Patients with Acute Coronary Syndrome Treated with Percutaneous Coronary Intervention

O. Amir, D. Leibowitz, D. Planer, 2021, Vascular health and risk management.

The Role Played by Transcription Factor E3 in Modulating Cardiac Hypertrophy.

R. Foo, E. Golomb, E. Razin, 2021, International heart journal.

Utilization of intra-aortic balloon pump to allow MitraClip procedure in patients with non-coapting mitral valve leaflets: a case series

R. Beeri, M. Shuvy, R. Eliaz, 2019, European Heart Journal: Case Reports.

Hyperphosphatemia is Required for Initiation, but not Propagation, of Kidney Failure-Induced Calcific Aortic Valve Disease.

D. Pereg, C. Lotan, R. Beeri, 2019, American journal of physiology. Heart and circulatory physiology.

Ticagrelor versus Prasugrel in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Analysis from the Acute Coronary Syndrome Israeli Survey

R. Beigel, Z. Iakobishvili, A. Levi, 2021, Cardiology.

Apoptotic cell therapy for cytokine storm associated with acute severe sepsis

D. Mevorach, R. Beeri, A. Abutbul, 2020, Cell Death & Disease.